Spots Global Cancer Trial Database for custirsen sodium
Every month we try and update this database with for custirsen sodium cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| OGX-011 and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Solid Tumors | NCT00471432 | Bladder Cancer Breast Cancer Kidney Cancer Lung Cancer Ovarian Cancer Prostate Cancer Unspecified Adu... | custirsen sodiu... docetaxel pharmacological... | 18 Years - 120 Years | Canadian Cancer Trials Group | |
| Hormone Therapy and OGX-011 Before Radical Prostatectomy in Treating Patients With Prostate Cancer | NCT00054106 | Prostate Cancer | buserelin custirsen sodiu... flutamide conventional su... neoadjuvant the... | 18 Years - 120 Years | Canadian Cancer Trials Group | |
| A Study of OGX-011/Gemcitabine/Platinum-Based Regimen in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) | NCT00138658 | Non-small Cell ... | custirsen sodiu... | 18 Years - | Achieve Life Sciences | |
| OGX-011 and Docetaxel in Treating Women With Locally Advanced or Metastatic Breast Cancer | NCT00258375 | Breast Cancer | custirsen sodiu... docetaxel | 18 Years - 120 Years | Canadian Cancer Trials Group | |
| Docetaxel and Prednisone With/Out OGX-011 in Recurrent or Metastatic Prostate Cancer That Did Not Respond to Previous Hormone Therapy | NCT00258388 | Prostate Cancer | custirsen sodiu... docetaxel prednisone | 18 Years - 120 Years | Canadian Cancer Trials Group | |
| Thorough QT/QTc (Corrected QT Interval) Study to Evaluate the Effect of Custirsen on Cardiac Repolarization | NCT01874561 | Cardiac Conduct... | Custirsen Placebo Moxifloxacin | 18 Years - 45 Years | Achieve Life Sciences | |
| Hormone Therapy and OGX-011 Before Radical Prostatectomy in Treating Patients With Prostate Cancer | NCT00054106 | Prostate Cancer | buserelin custirsen sodiu... flutamide conventional su... neoadjuvant the... | 18 Years - 120 Years | Canadian Cancer Trials Group | |
| OGX-011 and Docetaxel in Treating Women With Locally Advanced or Metastatic Breast Cancer | NCT00258375 | Breast Cancer | custirsen sodiu... docetaxel | 18 Years - 120 Years | Canadian Cancer Trials Group | |
| A Study Evaluating the Pain Palliation Benefit of Adding Custirsen to Docetaxel Retreatment or Cabazitaxel as Second Line Therapy in Men With Metastatic Castrate Resistant Prostate Cancer (mCRPC) | NCT01083615 | Castrate-Resist... Hormone Refract... | custirsen sodiu... isotonic, 0.9% ... docetaxel cabazitaxel prednisone | 18 Years - 99 Years | Achieve Life Sciences | |
| OGX-011 and Docetaxel in Treating Women With Locally Advanced or Metastatic Breast Cancer | NCT00258375 | Breast Cancer | custirsen sodiu... docetaxel | 18 Years - 120 Years | Canadian Cancer Trials Group | |
| A Study Evaluating the Pain Palliation Benefit of Adding Custirsen to Docetaxel Retreatment or Cabazitaxel as Second Line Therapy in Men With Metastatic Castrate Resistant Prostate Cancer (mCRPC) | NCT01083615 | Castrate-Resist... Hormone Refract... | custirsen sodiu... isotonic, 0.9% ... docetaxel cabazitaxel prednisone | 18 Years - 99 Years | Achieve Life Sciences |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
